共 29 条
[1]
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of REnal and vascular ENdstage disease (PREVEND) study and the prevention of REnal and vascular ENdstage disease intervention trial (PREVEND IT)
[J].
CLINICAL THERAPEUTICS,
2006, 28 (03)
:432-444
[2]
Screening for proteinuria in US adults - A cost-effectiveness analysis
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2003, 290 (23)
:3101-3114
[4]
Urinary albumin excretion as a predictor of the development of hypertension in the general population
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2006, 17 (02)
:331-335
[8]
Prevalence of chronic kidney disease in the United States
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2007, 298 (17)
:2038-2047
[9]
Screening for chronic kidney disease: Where does Europe go?
[J].
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2008, 3 (02)
:616-623
[10]
Screening, monitoring, and treatment of albuminuria: Public health perspectives
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2006, 17 (08)
:2120-2126